SANOFI CONS HEALTHC IND L Share Price

₹ 3,720.10

+₹397.30 (11.96%)

Last updated 29 Oct, 2026, 09:20 IST

NSE: SANOFICONR

SANOFI CONS HEALTHC IND L Share Price Today

As of 29 Oct 2026, SANOFI CONS HEALTHC IND L share price is ₹3,720.10. The stock opened at ₹3,502.20, compared to its previous close of ₹3,322.80. During today's trading session, SANOFI CONS HEALTHC IND L share price moved in the range of ₹3,502.20 to ₹3,771.90, with an average price of ₹3,637.05 for the day. Looking at its last 52-week, the stock has touched a low of ₹3,168.20 and a high of ₹5,255.00. On the performance front, SANOFI CONS HEALTHC IND L share price has declined by 29.04% over the last six months and is down 28.63% on a year-on-year basis.

₹3,502.20

11.96% up today

₹3,771.90

1D LOW

1D HIGH

SANOFI CONS HEALTHC IND L Stock Insights

Stock Performance

UnderperformingUnderperforming Nifty by 14.9 % in last 1 yr

Shareholding Pattern

DIIDII increased stake by 5.46%

Shareholding Pattern

FIIFII decreased stake by 4.50%

Stock Performance

UnderperformingUnderperforming Nifty by 14.9 % in last 1 yr

Shareholding Pattern

DIIDII increased stake by 5.46%

Shareholding Pattern

FIIFII decreased stake by 4.50%

Volume

65,216

Average traded price

₹3,694.70

Last traded time

09:20:47 29 Oct

Last traded quantity

₹2,658.30₹3,987.30

Circuit Low

Circuit High

₹3,168.20₹5,255.00

52-Week Low

52-Week High

Circuit

₹2,658.30

₹3,987.30

52-week

₹3,168.20

₹5,255.00

Mkt Cap Cr

7,747.96

P/E

42.27

P/B

35.83

ROA

51.64%

ROE

77.82%

ROCE

92.58%

Quick Ratio

3.37

EV/EBITDA

30.28

Mkt Cap Cr

7,747.96

P/E

42.27

P/B

35.83

ROA

51.64%

ROE

77.82%

ROCE

92.58%

Quick Ratio

3.37

EV/EBITDA

30.28

Based on fundamentals, this stock's

Performance

Very Poor

Sanofi Consumer has not beaten FD return of 7%

Valuation

Overvalued

Sanofi Consumer appears overvalued compared to its peers

Peer Comparison

Peer comparison — key ratios
Name	Mkt Cap Cr	P/E	P/B	ROA	ROE	ROCE	Quick Ratio	EV/EBITDA
Sun Pharmaceutical Industries	4,22,282.95	34.85	5.05	11.19%	13.74%	17.33%	2.31	21.18
Divis Laboratories	2,51,611.12	86.78	15.14	14.6%	15.32%	19.56%	3.5	57.29
Torrent Pharmaceuticals	1,75,182.22	82.64	9.44	4.7%	11.42%	11.37%	0.75	33.68
Zydus Lifesciences	1,16,907.45	25.35	4.29	8.57%	18.59%	17.35%	0.91	15.39
Laurus Labs	1,15,616.01	106.04	21.81	10.38%	16.77%	16.14%	0.68	54.44
Cipla	1,09,870.40	38.21	3.08	7.75%	11.27%	14.95%	2.5	18.58
Dr. Reddy's Laboratories	1,08,925.78	39.47	2.81	4.79%	7.21%	8.58%	1.35	18.49
Mankind Pharma	95,082.98	45.32	5.83	7.82%	12.76%	14.68%	0.74	25.11
Aurobindo Pharma	93,959.21	25.32	2.48	6.34%	9.25%	11.76%	1.15	11.7
Lupin	89,585.99	16.24	4.02	14.47%	23.76%	24.88%	1.42	9.54

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

SANOFI CONS HEALTHC IND L Company Background

ISIN

INE0UOS01011

Sector Market Cap

₹ 7,747.96 Cr

Sanofi Consumer Healthcare India Limited is an India-based company. It is engaged in the business of manufacturing, producing, processing, marketing, formulating, buying, trading, storing, packing, selling, distributing, importing, exporting, providing consultancy and otherwise dealing in all kinds of varieties of pharmaceuticals, especially consumer healthcare products, including: basic drugs; drug intermediates; chemical, medical, biological and electrolytic drugs, ingredients, Medicare, preparations and compositions; medicines, preparations and formulations in all or any forms, including formulations in which various drugs are processed; patents, medicines, drugs enzymes, fermentations and generic products, vitamin and vitamins products tonic, food products, nutritional products, products in therapies such as pain care, allergy, digestive health, cough & cold, sleep, general wellness and hormones and hormone products, and ingredients of every kind and other articles, and compounds.

SANOFI CONS HEALTHC IND L Financial Highlights

Revenue: SANOFI CONS HEALTHC IND L reported revenue of ₹896.80 crore in FY25 vs ₹896.80 crore in FY25. It showed an increase of 0.00% on a yearly basis.
Operating Profit: SANOFI CONS HEALTHC IND L reported an operating profit of ₹320.30 crore in FY25 vs ₹320.30 crore in FY25. It showed an increase of 0.00% on a year-on-year basis.
Net Profit: SANOFI CONS HEALTHC IND L reported a net profit of ₹240.10 crore in FY25 vs ₹240.10 crore in FY25. It showed an increase of 0.00% on a yearly basis.

SANOFI CONS HEALTHC IND L Quarterly Result Highlights

SANOFI CONS HEALTHC IND L reported revenue of ₹242.00 crore in Jun 2026, compared with ₹234.80 crore in Mar 2026, representing an increase of 3.07% on a quarter-on-quarter (QoQ) basis.
SANOFI CONS HEALTHC IND L reported an operating profit of ₹91.90 crore in Jun 2026, compared with ₹90.70 crore in Mar 2026, representing an increase of 1.32% on a quarter-on-quarter (QoQ) basis.
SANOFI CONS HEALTHC IND L reported a profit of ₹68.80 crore in Jun 2026, compared with ₹67.80 crore in Mar 2026, reflecting an increase of 1.47% on a QoQ basis.
The earnings per share (EPS) of SANOFI CONS HEALTHC IND L stood at ₹104.27 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more

Promoters

71.27%

FII

2.48%

Other DII

5.11%

Retail and other

8.22%

Mutual funds

12.92%

Foreign Institutional Investor (FII)

FII shareholding by period
Dec 2025	2.83%
Mar 2026	2.76%
Jun 2026	2.60%
Sep 2026	2.48%

1 day

-1.78%

1 week

-1.02%

1 month

-16.43%

1 year

-28.63%

3 years

-32.24%

5 years

-32.24%

Day

Open / Close

Change %

28 Oct 26

₹3,480.00 / ₹3,322.80

-1.78%

27 Oct 26

₹3,241.00 / ₹3,383.00

+4.10%

26 Oct 26

₹3,210.10 / ₹3,249.70

+1.30%

23 Oct 26

₹3,232.00 / ₹3,207.90

-1.68%

SANOFI CONS HEALTHC IND L Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
Particulars	Dec 2025	Dec 2024	Dec 2023
Revenue	₹878.40	₹724.50	₹555.40
Other Income	₹18.40	₹13.00	₹4.10
Total Revenue	₹896.80	₹737.50	₹559.50
Total Expenses	₹583.10	₹462.30	₹338.40
Profit Before Tax	₹320.30	₹246.80	₹219.30
Tax	₹80.20	₹65.80	₹54.40
Profit After Tax	₹240.10	₹181.00	₹164.90
EPS - Basic	₹104.27	₹78.59	₹71.60
EPS - Diluted	₹104.27	₹78.59	₹71.60

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
Particulars	Dec 2025	Dec 2024	Dec 2023
Profit before tax	₹320.30	₹246.80	₹219.30
Income before WC changes	₹316.00	₹247.30	₹217.10
Change in Assets	-₹52.40	₹266.00	-₹209.90
Change in Liabilities	-₹1.40	₹50.10	-₹3.40
Change in WC	-₹53.80	₹316.10	-₹213.30
Cash flow from Operations	₹174.80	₹439.00	-₹0.40
Cash flow from Investing	₹7.60	₹1.90	₹0.00
Cash flow from Financing	-₹134.50	-₹115.60	₹2.00
Total Cash Flow	₹47.90	₹325.30	₹1.60
Cash (Start of the year)	₹326.90	₹1.60	₹0.00
Cash (End of the year)	₹374.80	₹326.90	₹1.60

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
Particulars	Dec 2025	Dec 2024	Dec 2023
Non-Current Assets	₹52.70	₹39.60	₹10.20
Current Assets	₹494.30	₹391.70	₹335.20
Total Assets	₹547.00	₹431.30	₹345.40
Current Liabilities	₹128.40	₹130.60	₹129.90
Net Current Asset	₹365.90	₹261.10	₹205.30
Non-Current Liabilities	₹34.60	₹27.70	₹7.90
Equity Capital	₹384.00	₹273.00	₹207.60
Total Equity & Liabilities	₹547.00	₹431.30	₹345.40